HEALTH PROFESSIONAL · SOURCE READING
Treatment of Recurrent Adrenocortical Carcinoma
Source: Adrenocortical Carcinoma Treatment (PDQ®)–Health Professional Version, National Cancer Institute.
Source updated: December 13, 2024 · Captured 2026-09-09.
Selected source text with whitespace normalised. This Triangle page is not an NCI PDQ summary.
Deciding to treat patients with recurrent adrenocortical carcinoma (ACC), and what treatment to use, depends on many factors, including previous treatment, site of recurrence, and individual patient considerations. Local recurrence and selected sites of metastatic disease can sometimes be palliated by surgery or radiation therapy. Although recurrent ACC is not considered curable, palliation of hormonal symptoms and occasional 5-year survivals can be achieved.[1] However, substantial morbidity is associated with resection of recurrent tumors.
Source links and citations
Clinical trials, including phase I and II trials of newer chemotherapeutic and biological agents, are appropriate and should be considered.
Publication references
Read the original reference and check its publication notices.
Preserved source evidence · Not medical advice
Triangle